There are reports of a potential link between the medication Dupixent and an increased risk of certain types of cancer, including T-cell lymphoma. Lawsuits have been filed alleging that the manufacturer failed to adequately warn about this possible side effect. These lawsuits are being grouped together in a federal multidistrict litigation, although the outcome and details of the cases are not yet clear.